The effects of thrombolytic therapy on the high-resolution electrocardiogram after myocardial infarction

M Mäkijärvi1, J Heikkilä, J Montonen

  • 1Helsinki University Central Hospital, First Department of Medicine, Finland.

European Heart Journal
|August 1, 1992
PubMed

Insights

Thrombolytic treatment for acute myocardial infarction significantly shortened filtered QRS duration in reperfused patients. Early thrombolysis (within 2 hours) showed improved ECG markers, suggesting better outcomes.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Acute myocardial infarction (AMI) remains a leading cause of mortality.
  • Thrombolytic therapy is a critical treatment for AMI, aiming to restore blood flow.
  • Assessing treatment efficacy non-invasively is crucial for patient management.

Purpose of the Study:

  • To evaluate the effects of thrombolytic treatment on electrocardiographic (ECG) parameters in patients post-myocardial infarction.
  • To correlate ECG findings with treatment success and timing.
  • To investigate specific ECG markers indicative of successful reperfusion.

Main Methods:

  • High-resolution ECG, 24-hour Holter monitoring, exercise testing, and radionuclide ventriculography were used.
  • Analysis included filtered QRS duration and root mean square (RMS) voltage of the QRS complex.
  • Patients were categorized into treated (thrombolysis) and control groups.

Main Results:

  • Filtered QRS duration was significantly shorter in reperfused patients (83 ± 10 ms) compared to controls (89 ± 12 ms; P=0.017).
  • In inferior infarcts, reperfused patients had shorter filtered QRS duration (83 ± 11 ms vs. 89 ± 10 ms; P=0.044).
  • Higher RMS voltage in anteroseptal infarcts and earlier treatment groups indicated successful reperfusion.

Conclusions:

  • Thrombolytic therapy significantly impacts ECG parameters, particularly filtered QRS duration, in reperfused myocardial infarction.
  • Specific ECG metrics, like RMS voltage, can serve as indicators of successful reperfusion and treatment timing.
  • These findings support the use of advanced ECG analysis for assessing thrombolytic therapy effectiveness.

Related Concept Videos

Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
9.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522